Literature DB >> 27424009

Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells.

Rita Perfeito1, Márcio Ribeiro1,2, A Cristina Rego3,4.   

Abstract

Alpha-synuclein (α-syn) is a major component of Lewy bodies found in sporadic and inherited forms of Parkinson's disease (PD). Mutations in the gene encoding α-syn and duplications and triplications of wild-type (WT) α-syn have been associated with PD. Several mechanisms have been implicated in the degeneration of dopaminergic neurons in PD, including oxidative stress and mitochondrial dysfunction. Here we defined the occurrence of oxidative stress in SH-SY5Y cells overexpressing WT α-syn in a doxycycline (Dox) regulated manner, before and after exposure to iron (500 µM), and determined the changes in proteins involved in the intracellular antioxidant defense system. Data evidenced an increase in caspase-3 activation and diminished reducing capacity of -Dox cells, associated with decreased activity of mitochondria complex I and reduced mitochondrial transcription factor A (TFAM) levels in these cells. Furthermore, total and mitochondrial reactive oxygen species levels were higher under basal conditions in cells overexpressing α-syn (-Dox) and this increase was apparently correlated with diminished levels and activities of SOD1 and SOD2 in -Dox cells. Moreover, both reduced and oxidized glutathione levels were diminished in -Dox cells under basal conditions, concomitantly with decreased activity of GCL and reduced protein levels of GCLc. The effects caused by iron (500 µM) were mostly independent of α-syn expression and triggered different antioxidant responses to possibly counterbalance higher levels of free radicals. Overall, data suggest that overexpression of α-syn modifies the antioxidant capacity of SH-SY5Y cells due to altered activity and protein levels of SOD1 and SOD2, and decreased glutathione pool.

Entities:  

Keywords:  Antioxidant activity; Glutathione; Iron; Parkinson’s disease; ROS; Superoxide dismutase; α-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27424009     DOI: 10.1007/s00204-016-1788-6

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  11 in total

1.  α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.

Authors:  Jason F Cooper; Katie K Spielbauer; Megan M Senchuk; Saravanapriah Nadarajan; Monica P Colaiácovo; Jeremy M Van Raamsdonk
Journal:  Exp Neurol       Date:  2018-09-05       Impact factor: 5.330

2.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

3.  Oxygen Consumption Evaluation: An Important Indicator of Metabolic State, Cellular Function, and Cell Fate Along Neural Deregulation.

Authors:  Mariana Dutra Brito; Luiz Felipe Souza E Silva; Amanda Siena; Miruna Chipara; Sovan Sarkar; Tatiana Rosado Rosenstock
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Analysis of Mitochondrial Dysfunction by Microplate Reader in hiPSC-Derived Neuronal Cell Models of Neurodegenerative Disorders.

Authors:  Tatiana R Rosenstock; Congxin Sun; Georgina Wynne Hughes; Katherine Winter; Sovan Sarkar
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Calcium: Alpha-Synuclein Interactions in Alpha-Synucleinopathies.

Authors:  Alexandre N Rcom-H'cheo-Gauthier; Samantha L Osborne; Adrian C B Meedeniya; Dean L Pountney
Journal:  Front Neurosci       Date:  2016-12-20       Impact factor: 4.677

6.  Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses.

Authors:  Nicholas G Norwitz; Adrian Soto Mota; Sam G Norwitz; Kieran Clarke
Journal:  Front Aging Neurosci       Date:  2019-07-31       Impact factor: 5.750

Review 7.  Gut Inflammation in Association With Pathogenesis of Parkinson's Disease.

Authors:  Qian-Qian Chen; Caroline Haikal; Wen Li; Jia-Yi Li
Journal:  Front Mol Neurosci       Date:  2019-09-13       Impact factor: 5.639

Review 8.  Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.

Authors:  Julia Konovalova; Dmytro Gerasymchuk; Ilmari Parkkinen; Piotr Chmielarz; Andrii Domanskyi
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

9.  The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process.

Authors:  Chiara Lenzi; Ileana Ramazzina; Isabella Russo; Alice Filippini; Saverio Bettuzzi; Federica Rizzi
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

Review 10.  Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson's Disease: Current Knowledge and Future Perspectives.

Authors:  Rengasamy Balakrishnan; Shofiul Azam; Duk-Yeon Cho; In Su-Kim; Dong-Kug Choi
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.